2025-09-05 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
1,072,233 |
1,478,647 |
|
|
|
2025-07-08 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
|
1,072,233 |
|
|
|
2025-07-08 |
13G/A
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
3,707,364 |
4,599,450 |
|
|
|
2025-06-04 |
13G/A
|
SPCE / Virgin Galactic Holdings, Inc.
|
|
1,956,199 |
209,985 |
|
|
|
2025-04-07 |
13G
|
SPCE / Virgin Galactic Holdings, Inc.
|
|
|
1,956,199 |
|
|
|
2025-01-08 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
7,128,250 |
6,428,250 |
|
|
|
2025-01-08 |
13G/A
|
ATYR / aTyr Pharma, Inc.
|
|
14,666,600 |
14,666,600 |
|
|
|
2024-11-06 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
7,128,250 |
7,128,250 |
|
|
|
2024-11-06 |
13G
|
EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
3,707,364 |
|
|
|
2024-10-07 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
8,094,700 |
7,128,250 |
|
|
|
2024-10-07 |
13G/A
|
ATYR / aTyr Pharma, Inc.
|
|
10,169,600 |
14,666,600 |
|
|
|
2024-10-07 |
13G
|
SDHC / Smith Douglas Homes Corp.
|
|
|
527,300 |
|
|
|
2024-09-09 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
11,364,666 |
6,158,200 |
|
|
|
2024-04-08 |
13G/A
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
10,716,153 |
95,000 |
|
|
|
2024-03-25 |
13D
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
10,886,153 |
10,716,153 |
|
|
|
2024-03-06 |
13G/A
|
MRUS / Merus N.V.
|
|
3,637,309 |
2,297,700 |
|
|
|
2024-03-06 |
13G/A
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
3,272,761 |
2,165,071 |
|
|
|
2024-02-07 |
13G/A
|
PX / P10, Inc.
|
|
3,181,933 |
2,600,000 |
|
|
|
2024-01-18 |
13G/A
|
SSTI / SoundThinking, Inc.
|
|
1,320,594 |
1,315,000 |
|
|
|
2024-01-18 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
6,866,914 |
8,094,700 |
|
|
|
2024-01-18 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
7,550,274 |
8,250,274 |
|
|
|
2024-01-18 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
3,875,578 |
4,023,860 |
|
|
|
2024-01-18 |
13G/A
|
PX / P10, Inc.
|
|
3,181,933 |
3,181,933 |
|
|
|
2024-01-18 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
1,201,275 |
1,351,275 |
|
|
|
2024-01-18 |
13G/A
|
MRUS / Merus N.V.
|
|
2,138,700 |
3,637,309 |
|
|
|
2024-01-18 |
13G/A
|
ATYR / aTyr Pharma, Inc.
|
|
5,231,600 |
10,169,600 |
|
|
|
2024-01-18 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
2,864,500 |
3,883,775 |
|
|
|
2024-01-18 |
13G/A
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
10,633,789 |
10,886,153 |
|
|
|
2024-01-18 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
12,640,363 |
11,364,666 |
|
|
|
2024-01-17 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
4,239,554 |
4,711,512 |
|
|
|
2024-01-17 |
13G/A
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
3,284,217 |
3,272,761 |
|
|
|
2023-11-07 |
13G/A
|
MCRB / Seres Therapeutics, Inc.
|
|
11,500,520 |
5,175,805 |
|
|
|
2023-09-07 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
6,304,482 |
2,341,335 |
|
|
|
2023-08-08 |
13G/A
|
ANNX / Annexon, Inc.
|
|
3,057,800 |
2,342,715 |
|
|
|
2023-06-09 |
13G/A
|
MNK / Mallinckrodt PLC
|
|
998,958 |
515,988 |
|
|
|
2023-06-09 |
13G/A
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
3,224,100 |
10,633,789 |
|
|
|
2023-05-10 |
13G/A
|
MCRB / Seres Therapeutics, Inc.
|
|
18,085,938 |
11,500,520 |
|
|
|
2023-05-10 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
2,904,826 |
3,875,578 |
|
|
|
2023-04-10 |
13G/A
|
XPOF / Xponential Fitness, Inc.
|
|
1,875,000 |
1,627,737 |
|
|
|
2023-04-10 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
8,401,687 |
840,169 |
|
|
|
2023-04-10 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
1,956,488 |
0 |
|
|
|
2023-03-10 |
13G/A
|
MRUS / Merus N.V.
|
|
3,924,295 |
2,138,700 |
|
|
|
2023-03-10 |
13G/A
|
ARIS / Aris Water Solutions, Inc.
|
|
2,588,600 |
1,399,900 |
|
|
|
2023-02-09 |
13G/A
|
US14757U2087 / CASI Pharmaceuticals Inc
|
|
900,651 |
661,070 |
|
|
|
2023-02-09 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
2,373,023 |
1,401,559 |
|
|
|
2023-02-09 |
13G/A
|
ALEC / Alector, Inc.
|
|
4,571,660 |
2,824,387 |
|
|
|
2023-02-01 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
8,309,859 |
8,401,687 |
|
|
|
2023-02-01 |
13G/A
|
PX / P10, Inc.
|
|
2,822,860 |
3,181,933 |
|
|
|
2023-02-01 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
29,048,265 |
2,904,826 |
|
|
|
2023-02-01 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
3,189,222 |
7,550,274 |
|
|
|
2023-02-01 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
5,915,664 |
6,866,914 |
|
|
|
2023-02-01 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
5,065,113 |
6,304,482 |
|
|
|
2023-02-01 |
13G/A
|
MCRB / Seres Therapeutics, Inc.
|
|
17,982,256 |
18,085,938 |
|
|
|
2023-02-01 |
13G/A
|
SSTI / SoundThinking, Inc.
|
|
123,500 |
1,320,594 |
|
|
|
2023-02-01 |
13G/A
|
XPOF / Xponential Fitness, Inc.
|
|
1,400,000 |
1,875,000 |
|
|
|
2023-02-01 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
|
1,201,275 |
|
|
|
2023-02-01 |
13G/A
|
MRUS / Merus N.V.
|
|
3,679,300 |
3,924,295 |
|
|
|
2023-02-01 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
2,290,282 |
2,864,500 |
|
|
|
2023-02-01 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
16,782,838 |
12,640,363 |
|
|
|
2023-02-01 |
13G/A
|
US14757U2087 / CASI Pharmaceuticals Inc
|
|
|
900,651 |
|
|
|
2023-02-01 |
13G/A
|
ATYR / aTyr Pharma, Inc.
|
|
5,222,250 |
5,231,600 |
|
|
|
2023-02-01 |
13G/A
|
ARIS / Aris Water Solutions, Inc.
|
|
2,588,600 |
2,588,600 |
|
|
|
2023-02-01 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
3,694,929 |
4,239,554 |
|
|
|
2023-02-01 |
13G/A
|
ANNX / Annexon, Inc.
|
|
2,025,600 |
3,057,800 |
|
|
|
2023-02-01 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,319,173 |
2,373,023 |
|
|
|
2023-02-01 |
13G/A
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
3,464,335 |
3,284,217 |
|
|
|
2023-02-01 |
13G/A
|
ALEC / Alector, Inc.
|
|
|
4,571,660 |
|
|
|
2023-02-01 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
2,358,624 |
1,956,488 |
|
|
|
2023-02-01 |
13G
|
MNK / Mallinckrodt PLC
|
|
|
998,958 |
|
|
|
2023-02-01 |
13G
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
|
3,224,100 |
|
|
|
2023-01-10 |
13G/A
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
3,986,870 |
3,094,500 |
|
|
|
2023-01-10 |
13G/A
|
OMEG / Omega Alpha SPAC - Class A
|
|
1,000,000 |
0 |
|
|
|
2023-01-10 |
13G/A
|
AKUS / Akouos Inc
|
|
3,897,903 |
0 |
|
|
|
2022-12-07 |
13G/A
|
BLSA / BCLS Acquisition Corp - Class A
|
|
1,000,000 |
0 |
|
|
|
2022-11-09 |
13G/A
|
ARIS / Aris Water Solutions, Inc.
|
|
1,250,000 |
2,588,600 |
|
|
|
2022-09-09 |
13G/A
|
OTIC / Otonomy Inc
|
|
3,923,700 |
0 |
|
|
|
2022-09-09 |
13G/A
|
CFRX / ContraFect Corp
|
|
7,297,188 |
1,685,391 |
|
|
|
2022-09-09 |
13G/A
|
AKUS / Akouos Inc
|
|
2,498,442 |
3,897,903 |
|
|
|
2022-08-10 |
13G/A
|
DOMO / Domo, Inc.
|
|
1,713,217 |
1,116,050 |
|
|
|
2022-07-11 |
13G/A
|
MCRB / Seres Therapeutics, Inc.
|
|
6,914,136 |
17,982,256 |
|
|
|
2022-06-10 |
13G/A
|
SSTI / SoundThinking, Inc.
|
|
1,120,000 |
123,500 |
|
|
|
2022-06-10 |
13G/A
|
STEP / StepStone Group Inc.
|
|
3,467,320 |
3,021,896 |
|
|
|
2022-06-10 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
2,801,066 |
1,552,239 |
|
|
|
2022-06-10 |
13G/A
|
GMDA / Gamida Cell Ltd.
|
|
4,363,315 |
2,539,164 |
|
|
|
2022-05-16 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
29,048,265 |
|
|
|
2022-05-10 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,604,287 |
1,319,173 |
|
|
|
2022-05-10 |
13G/A
|
AVRO / AVROBIO, Inc.
|
|
2,595,453 |
597,781 |
|
|
|
2022-04-11 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,803,335 |
5,065,113 |
|
|
|
2022-04-11 |
13G/A
|
BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
|
|
28,838,088 |
272,751 |
|
|
|
2022-02-14 |
13G/A
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
4,280,528 |
3,986,870 |
|
|
|
2022-02-14 |
13G/A
|
STEP / StepStone Group Inc.
|
|
3,467,483 |
3,467,320 |
|
|
|
2022-02-14 |
13G/A
|
SSTI / SoundThinking, Inc.
|
|
1,074,672 |
1,120,000 |
|
|
|
2022-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
5,449,253 |
5,915,664 |
|
|
|
2022-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
1,775,704 |
2,803,335 |
|
|
|
2022-02-14 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
3,189,222 |
3,189,222 |
|
|
|
2022-02-14 |
13G/A
|
PX / P10, Inc.
|
|
2,776,503 |
2,822,860 |
|
|
|
2022-02-14 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
9,610,200 |
9,610,200 |
|
|
|
2022-02-14 |
13G/A
|
BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
|
|
29,983,326 |
28,838,088 |
|
|
|
2022-02-14 |
13G
|
XPOF / Xponential Fitness, Inc.
|
|
|
1,400,000 |
|
|
|
2022-02-14 |
13G
|
MCRB / Seres Therapeutics, Inc.
|
|
|
6,914,136 |
|
|
|
2022-02-14 |
13G
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
2,290,282 |
|
|
|
2022-02-14 |
13G
|
DOMO / Domo, Inc.
|
|
|
1,713,217 |
|
|
|
2022-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
4,282,563 |
2,358,624 |
|
|
|
2022-02-14 |
13G
|
ANNX / Annexon, Inc.
|
|
|
2,025,600 |
|
|
|
2022-02-14 |
13G/A
|
AKUS / Akouos Inc
|
|
2,319,482 |
2,498,442 |
|
|
|
2022-02-14 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
1,273,767 |
1,604,287 |
|
|
|
2022-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
4,282,563 |
5,280,847 |
|
|
|
2022-02-14 |
13G/A
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
7,000,000 |
3,464,335 |
|
|
|
2022-02-14 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
5,222,250 |
5,222,250 |
|
|
|
2022-02-14 |
13G
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
8,309,859 |
|
|
|
2022-02-14 |
13G/A
|
BLSA / BCLS Acquisition Corp - Class A
|
|
1,000,000 |
1,000,000 |
|
|
|
2022-02-14 |
13G
|
OMEG / Omega Alpha SPAC - Class A
|
|
|
1,000,000 |
|
|
|
2022-02-14 |
13G/A
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
7,000,000 |
10,150,000 |
|
|
|
2022-02-14 |
13G
|
BRZE / Braze, Inc.
|
|
|
530,000 |
|
|
|
2022-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
5,297,188 |
7,297,188 |
|
|
|
2022-02-14 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
12,521,800 |
16,782,838 |
|
|
|
2022-02-14 |
13G
|
AVRO / AVROBIO, Inc.
|
|
|
2,595,453 |
|
|
|
2022-02-14 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
3,601,272 |
2,801,066 |
|
|
|
2022-02-14 |
13G/A
|
GMDA / Gamida Cell Ltd.
|
|
5,052,523 |
4,363,315 |
|
|
|
2022-02-14 |
13G
|
RNA / Avidity Biosciences, Inc.
|
|
|
2,474,500 |
|
|
|
2022-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
2,936,798 |
3,679,300 |
|
|
|
2022-02-14 |
13G
|
ARIS / Aris Water Solutions, Inc.
|
|
|
1,250,000 |
|
|
|
2022-02-14 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
3,452,810 |
3,694,929 |
|
|
|
2022-02-14 |
13G/A
|
OTIC / Otonomy Inc
|
|
4,856,200 |
3,923,700 |
|
|
|
2022-02-10 |
13G/A
|
IMXI / International Money Express, Inc.
|
|
2,834,830 |
1,076,231 |
|
|
|
2022-02-10 |
13G/A
|
IMXI / International Money Express, Inc.
|
|
2,834,830 |
2,196,964 |
|
|
|
2021-12-10 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
2,129,553 |
5,449,253 |
|
|
|
2021-12-10 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,617,600 |
1,775,704 |
|
|
|
2021-12-10 |
13G/A
|
QRHC / Quest Resource Holding Corporation
|
|
1,476,405 |
477,830 |
|
|
|
2021-12-10 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
7,442,600 |
1,418 |
|
|
|
2021-11-10 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
1,259,122 |
3,189,222 |
|
|
|
2021-11-10 |
13G
|
PX / P10, Inc.
|
|
|
2,776,503 |
|
|
|
2021-10-08 |
13G/A
|
STEP / StepStone Group Inc.
|
|
3,591,977 |
3,467,483 |
|
|
|
2021-10-08 |
13G/A
|
MX / Magnachip Semiconductor Corporation
|
|
2,959,604 |
1,998,604 |
|
|
|
2021-10-08 |
13G/A
|
QRHC / Quest Resource Holding Corporation
|
|
2,525,000 |
1,476,405 |
|
|
|
2021-10-08 |
13G/A
|
GDYN / Grid Dynamics Holdings, Inc.
|
|
2,744,600 |
2,410,539 |
|
|
|
2021-10-08 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
1,615,000 |
5,222,250 |
|
|
|
2021-07-09 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,950,000 |
1,562,733 |
|
|
|
2021-07-09 |
13G/A
|
CAMT / Camtek Ltd.
|
|
2,580,000 |
2,135,000 |
|
|
|
2021-06-10 |
13G/A
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
2,233,333 |
|
|
|
2021-04-09 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
1,666,538 |
3,601,272 |
|
|
|
2021-04-09 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,235,033 |
1,950,000 |
|
|
|
2021-04-09 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
1,615,000 |
1,615,000 |
|
|
|
2021-04-09 |
13G
|
STEP / StepStone Group Inc.
|
|
|
3,591,977 |
|
|
|
2021-03-10 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
1,731,788 |
1,666,538 |
|
|
|
2021-03-10 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
2,129,553 |
2,129,553 |
|
|
|
2021-02-12 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
3,766,365 |
4,282,563 |
|
|
|
2021-02-12 |
13G
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
|
7,000,000 |
|
|
|
2021-02-12 |
13G
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
2,617,600 |
|
|
|
2021-02-12 |
13G
|
MX / Magnachip Semiconductor Corporation
|
|
|
2,959,604 |
|
|
|
2021-02-12 |
13G
|
IMXI / International Money Express, Inc.
|
|
|
2,834,830 |
|
|
|
2021-02-12 |
13G
|
GDYN / Grid Dynamics Holdings, Inc.
|
|
|
2,744,600 |
|
|
|
2021-02-12 |
13G
|
GMDA / Gamida Cell Ltd.
|
|
|
5,052,523 |
|
|
|
2021-02-12 |
13G
|
FREQ / Frequency Therapeutics Inc
|
|
|
1,731,788 |
|
|
|
2021-02-12 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
1,562,500 |
1,235,033 |
|
|
|
2021-02-12 |
13G
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
1,000,000 |
|
|
|
2021-02-12 |
13G
|
AMPH / Amphastar Pharmaceuticals, Inc.
|
|
|
3,225,883 |
|
|
|
2021-02-12 |
13G
|
AKUS / Akouos Inc
|
|
|
2,319,482 |
|
|
|
2021-02-12 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
6,934,600 |
7,442,600 |
|
|
|
2021-02-12 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
595,072 |
1,615,000 |
|
|
|
2021-02-12 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
3,766,365 |
2,447,000 |
|
|
|
2021-02-12 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,562,500 |
1,562,500 |
|
|
|
2021-02-12 |
13G/A
|
QURE / uniQure N.V.
|
|
3,011,446 |
3,855,615 |
|
|
|
2021-02-12 |
13G/A
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
2,972,008 |
4,280,528 |
|
|
|
2021-02-12 |
13G/A
|
SSTI / SoundThinking, Inc.
|
|
1,047,948 |
1,074,672 |
|
|
|
2021-02-12 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
18,610,412 |
2,129,553 |
|
|
|
2021-02-12 |
13G/A
|
RZLT / Rezolute, Inc.
|
|
1,259,122 |
1,259,122 |
|
|
|
2021-02-12 |
13G/A
|
QRHC / Quest Resource Holding Corporation
|
|
1,825,000 |
2,525,000 |
|
|
|
2021-02-12 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
9,610,200 |
9,610,200 |
|
|
|
2021-02-12 |
13G/A
|
MRUS / Merus N.V.
|
|
2,936,798 |
2,936,798 |
|
|
|
2021-02-12 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
9,821,800 |
12,521,800 |
|
|
|
2021-02-12 |
13G/A
|
CFRX / ContraFect Corp
|
|
30,500,000 |
5,297,188 |
|
|
|
2021-02-12 |
13G/A
|
CAMT / Camtek Ltd.
|
|
2,000,000 |
2,580,000 |
|
|
|
2021-02-10 |
13G/A
|
OTIC / Otonomy Inc
|
|
0 |
4,856,200 |
|
|
|
2021-02-10 |
13G/A
|
BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
|
|
15,639,073 |
29,983,326 |
|
|
|
2021-02-10 |
13G/A
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
106,616 |
|
|
|
2021-02-10 |
13G/A
|
DMTK / DermTech, Inc.
|
|
|
1,093,113 |
|
|
|
2021-02-10 |
13G/A
|
OTIC / Otonomy Inc
|
|
0 |
3,930,649 |
|
|
|
2021-02-10 |
13G/A
|
BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
|
|
15,639,073 |
23,157,798 |
|
|
|
2021-02-10 |
13G
|
DMTK / DermTech, Inc.
|
|
|
1,093,113 |
|
|
|
2021-02-10 |
13G
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
641,178 |
|
|
|
2021-01-08 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
3,452,810 |
|
|
|
2020-11-10 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
2,122,800 |
1,562,500 |
|
|
|
2020-11-10 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
1,437,000 |
3,766,365 |
|
|
|
2020-11-10 |
13G
|
RZLT / Rezolute, Inc.
|
|
|
1,259,122 |
|
|
|
2020-11-10 |
13G
|
MRUS / Merus N.V.
|
|
|
2,936,798 |
|
|
|
2020-08-10 |
13G/A
|
NFE / New Fortress Energy Inc.
|
|
2,312,691 |
3,328,700 |
|
|
|
2020-08-10 |
13G/A
|
NAUT / Nautilus Biotechnology, Inc.
|
|
750,000 |
0 |
|
|
|
2020-04-09 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
8,874,400 |
5,216,832 |
|
|
|
2020-04-09 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
2,378,300 |
1,273,767 |
|
|
|
2020-02-14 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
9,326,450 |
9,821,800 |
|
|
|
2020-02-14 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
11,604,789 |
8,874,400 |
|
|
|
2020-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
6,868,400 |
18,610,412 |
|
|
|
2020-02-14 |
13G/A
|
QRHC / Quest Resource Holding Corporation
|
|
1,825,000 |
1,825,000 |
|
|
|
2020-02-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,043,400 |
2,122,800 |
|
|
|
2020-02-14 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
4,215,063 |
6,934,600 |
|
|
|
2020-02-14 |
13G/A
|
QURE / uniQure N.V.
|
|
1,353,682 |
3,011,446 |
|
|
|
2020-02-14 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
9,605,287 |
9,610,200 |
|
|
|
2020-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
3,816,300 |
1,437,000 |
|
|
|
2020-02-14 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
7,393,715 |
595,072 |
|
|
|
2020-02-13 |
13G
|
CAMT / Camtek Ltd.
|
|
|
2,000,000 |
|
|
|
2020-02-13 |
13G
|
SSTI / SoundThinking, Inc.
|
|
|
1,047,948 |
|
|
|
2020-02-13 |
13G
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
2,972,008 |
|
|
|
2020-02-13 |
13G
|
ALBO / Albireo Pharma Inc
|
|
1,437,000 |
3,816,300 |
|
|
|
2020-02-13 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
|
2,378,300 |
|
|
|
2020-02-13 |
13G
|
NAUT / Nautilus Biotechnology, Inc.
|
|
|
750,000 |
|
|
|
2020-02-10 |
13G/A
|
NFE / New Fortress Energy Inc.
|
|
|
2,312,691 |
|
|
|
2020-02-10 |
13G/A
|
BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
|
|
10,055,784 |
15,639,073 |
|
|
|
2020-02-10 |
13G
|
NFE / New Fortress Energy Inc.
|
|
|
2,163,714 |
|
|
|
2020-01-10 |
13G/A
|
CFRX / ContraFect Corp
|
|
4,000,000 |
30,500,000 |
|
|
|
2019-12-10 |
13G
|
QRHC / Quest Resource Holding Corporation
|
|
|
1,825,000 |
|
|
|
2019-12-10 |
13G/A
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
3,036,344 |
1,895,001 |
|
|
|
2019-12-10 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
7,535,287 |
9,605,287 |
|
|
|
2019-09-10 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
3,661,600 |
9,326,450 |
|
|
|
2019-06-07 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
1,437,000 |
|
|
|
2019-05-10 |
13G/A
|
CALA / Calithera Biosciences, Inc.
|
|
3,548,894 |
4,215,063 |
|
|
|
2019-04-22 |
13G
|
LIFE / aTyr Pharma, Inc.
|
|
|
7,393,715 |
|
|
|
2019-04-10 |
13G/A
|
CFRX / ContraFect Corp
|
|
8,441,200 |
4,000,000 |
|
|
|
2019-04-10 |
13G/A
|
HLNE / Hamilton Lane Incorporated
|
|
1,304,185 |
1,149,200 |
|
|
|
2019-03-08 |
13G/A
|
QURE / uniQure N.V.
|
|
1,565,600 |
1,353,682 |
|
|
|
2019-02-13 |
13G
|
CALA / Calithera Biosciences, Inc.
|
|
|
3,548,894 |
|
|
|
2019-02-13 |
13G/A
|
CFRX / ContraFect Corp
|
|
8,000,000 |
8,441,200 |
|
|
|
2019-02-13 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
10,434,000 |
1,043,400 |
|
|
|
2019-02-13 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
12,624,012 |
11,604,789 |
|
|
|
2019-02-13 |
13G/A
|
HLNE / Hamilton Lane Incorporated
|
|
1,160,387 |
1,304,185 |
|
|
|
2019-02-13 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
7,535,287 |
7,535,287 |
|
|
|
2019-02-13 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
4,208,400 |
6,868,400 |
|
|
|
2019-02-13 |
13G
|
QURE / uniQure N.V.
|
|
|
1,565,600 |
|
|
|
2019-02-13 |
13G
|
BZUN / Baozun Inc. - Depositary Receipt (Common Stock)
|
|
|
10,055,784 |
|
|
|
2019-02-13 |
13G
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
3,036,344 |
|
|
|
2019-02-13 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
2,711,425 |
3,661,600 |
|
|
|
2018-12-07 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
6,996,055 |
3,501,477 |
|
|
|
2018-10-10 |
13G/A
|
HLNE / Hamilton Lane Incorporated
|
|
1,218,645 |
1,160,387 |
|
|
|
2018-08-10 |
13G/A
|
STDY / SteadyMed Ltd.
|
|
2,145,697 |
822,570 |
|
|
|
2018-07-10 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
10,187,763 |
6,996,055 |
|
|
|
2018-07-10 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
10,434,000 |
|
|
|
2018-06-08 |
13G/A
|
STDY / SteadyMed Ltd.
|
|
4,681,326 |
2,145,697 |
|
|
|
2018-03-09 |
13G/A
|
ONCE / Spark Therapeutics, Inc.
|
|
1,851,400 |
1,497,788 |
|
|
|
2018-02-14 |
13G/A
|
STDY / SteadyMed Ltd.
|
|
4,040,044 |
4,681,326 |
|
|
|
2018-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
3,633,360 |
4,208,400 |
|
|
|
2018-02-14 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
6,358,642 |
7,535,287 |
|
|
|
2018-02-14 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
12,287,200 |
10,187,763 |
|
|
|
2018-02-14 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
13,878,000 |
12,624,012 |
|
|
|
2018-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
8,000,000 |
8,000,000 |
|
|
|
2018-02-14 |
13G
|
ONCE / Spark Therapeutics, Inc.
|
|
|
1,851,400 |
|
|
|
2018-02-14 |
13G
|
HLNE / Hamilton Lane Incorporated
|
|
|
1,218,645 |
|
|
|
2017-09-08 |
13G/A
|
OTIC / Otonomy Inc
|
|
2,937,800 |
0 |
|
|
|
2017-08-09 |
13G/A
|
CFRX / ContraFect Corp
|
|
4,000,000 |
8,000,000 |
|
|
|
2017-08-09 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
3,619,173 |
2,711,425 |
|
|
|
2017-08-09 |
13G/A
|
ZGNX / Zogenix Inc
|
|
2,665,750 |
1,176,900 |
|
|
|
2017-07-10 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
5,436,372 |
4,845,682 |
|
|
|
2017-03-09 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
2,380,600 |
1,230,300 |
|
|
|
2017-02-14 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
925,604 |
5,436,372 |
|
|
|
2017-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
3,408,360 |
3,633,360 |
|
|
|
2017-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
3,372,356 |
2,665,750 |
|
|
|
2017-02-14 |
13G/A
|
STDY / SteadyMed Ltd.
|
|
2,103,278 |
4,040,044 |
|
|
|
2017-02-14 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
953,500 |
2,380,600 |
|
|
|
2017-02-14 |
13G/A
|
XENT / Intersect ENT Inc
|
|
1,489,103 |
1,314,843 |
|
|
|
2017-02-14 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
5,058,642 |
6,358,642 |
|
|
|
2017-02-14 |
13G/A
|
OTIC / Otonomy Inc
|
|
2,479,516 |
2,937,800 |
|
|
|
2017-02-14 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
13,508,290 |
12,287,200 |
|
|
|
2017-02-14 |
13G
|
CFRX / ContraFect Corp
|
|
|
4,000,000 |
|
|
|
2017-02-14 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
14,189,245 |
13,878,000 |
|
|
|
2017-02-14 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
2,977,629 |
3,619,173 |
|
|
|
2016-08-10 |
13G/A
|
OCUL / Ocular Therapeutix, Inc.
|
|
1,647,233 |
266,251 |
|
|
|
2016-08-10 |
13G/A
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
2,528,773 |
2,127,873 |
|
|
|
2016-07-08 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
1,233,360 |
3,408,360 |
|
|
|
2016-07-08 |
13G/A
|
TXTR / Textura Corp.
|
|
3,319,600 |
0 |
|
|
|
2016-06-09 |
13G/A
|
PINC / Premier, Inc.
|
|
2,411,650 |
2,232,300 |
|
|
|
2016-06-09 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
2,053,453 |
953,500 |
|
|
|
2016-05-10 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
2,960,554 |
2,420,700 |
|
|
|
2016-05-09 |
13G/A
|
IOTS / Adesto Technologies Corporation
|
|
994,000 |
598,351 |
|
|
|
2016-05-09 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
4,582,320 |
0 |
|
|
|
2016-04-08 |
13G/A
|
TSQ / Townsquare Media, Inc.
|
|
506,524 |
482,295 |
|
|
|
2016-04-08 |
13G/A
|
ECOM / ChannelAdvisor Corp
|
|
1,363,648 |
1,250,781 |
|
|
|
2016-02-12 |
13G/A
|
ZGNX / Zogenix Inc
|
|
21,048,000 |
3,372,356 |
|
|
|
2016-02-12 |
13G/A
|
TSQ / Townsquare Media, Inc.
|
|
|
506,524 |
|
|
|
2016-02-11 |
13G/A
|
NERV / Minerva Neurosciences, Inc.
|
|
4,938,222 |
5,058,642 |
|
|
|
2016-02-11 |
13G/A
|
STDY / SteadyMed Ltd.
|
|
1,627,078 |
2,103,278 |
|
|
|
2016-02-11 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
13,508,290 |
|
|
|
2016-02-11 |
13G/A
|
ZCOR / Zyla Life Sciences
|
|
|
2,053,453 |
|
|
|
2016-02-11 |
13G/A
|
PINC / Premier, Inc.
|
|
2,411,650 |
2,411,650 |
|
|
|
2016-02-11 |
13G/A
|
TXTR / Textura Corp.
|
|
|
3,319,600 |
|
|
|
2016-02-11 |
13G
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
1,102,773 |
2,528,773 |
|
|
|
2016-02-11 |
13G
|
IOTS / Adesto Technologies Corporation
|
|
|
994,000 |
|
|
|
2016-02-11 |
13G
|
OCUL / Ocular Therapeutix, Inc.
|
|
|
1,647,233 |
|
|
|
2016-02-11 |
13G
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
4,582,320 |
|
|
|
2016-02-11 |
13G
|
XENT / Intersect ENT Inc
|
|
|
1,489,103 |
|
|
|
2016-02-11 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
|
1,233,360 |
|
|
|
2016-02-11 |
13G/A
|
ECOM / ChannelAdvisor Corp
|
|
|
1,363,648 |
|
|
|
2016-02-11 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
2,451,694 |
2,960,554 |
|
|
|
2016-02-11 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
|
14,189,245 |
|
|
|
2016-02-11 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
2,974,479 |
2,977,629 |
|
|
|
2016-02-09 |
13G/A
|
DYAX / Dyax Corp.
|
|
9,176,181 |
0 |
|
|
|
2016-02-08 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
9,176,181 |
|
|
|
2016-01-08 |
13G/A
|
EXAM / ExamWorks Group, Inc.
|
|
|
1,959,661 |
|
|
|
2016-01-08 |
13G
|
OTIC / Otonomy Inc
|
|
|
2,479,516 |
|
|
|
2016-01-08 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
0 |
|
|
|
2015-11-10 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
925,604 |
|
|
|
2015-08-07 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
2,974,479 |
|
|
|
2015-08-07 |
13G/A
|
B0BK18905 / Central European Media Enterprises Ltd.
|
|
|
6,706,294 |
|
|
|
2015-05-07 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
|
2,451,694 |
|
|
|
2015-04-09 |
13G/A
|
DXCM / DexCom, Inc.
|
|
|
3,576,533 |
|
|
|
2015-04-09 |
13G
|
NERV / Minerva Neurosciences, Inc.
|
|
|
4,938,222 |
|
|
|
2015-04-09 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
21,048,000 |
|
|
|
2015-04-09 |
13G
|
STDY / SteadyMed Ltd.
|
|
|
1,627,078 |
|
|
|
2015-02-11 |
13G/A
|
DXCM / DexCom, Inc.
|
|
|
3,962,533 |
|
|
|
2015-02-11 |
13G/A
|
TXTR / Textura Corp.
|
|
|
3,405,584 |
|
|
|
2015-02-11 |
13G/A
|
EXAM / ExamWorks Group, Inc.
|
|
|
2,349,510 |
|
|
|
2015-02-11 |
13G/A
|
PINC / Premier, Inc.
|
|
|
3,384,814 |
|
|
|
2015-02-11 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
34,514,700 |
|
|
|
2015-02-11 |
13G/A
|
TSQ / Townsquare Media, Inc.
|
|
|
605,179 |
|
|
|
2015-02-11 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
10,270,101 |
|
|
|
2015-02-11 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
4,041,793 |
|
|
|
2015-02-11 |
13G
|
ZCOR / Zyla Life Sciences
|
|
|
1,407,600 |
|
|
|
2015-02-11 |
13G
|
ECOM / ChannelAdvisor Corp
|
|
|
1,848,087 |
|
|
|
2015-02-11 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
|
4,377,696 |
|
|
|
2015-02-11 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
12,461,400 |
|
|
|
2015-02-11 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
3,755,667 |
|
|
|
2015-02-11 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
13,508,290 |
|
|
|
2015-02-11 |
13G/A
|
B0BK18905 / Central European Media Enterprises Ltd.
|
|
|
10,285,328 |
|
|
|
2015-02-11 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
|
14,191,470 |
|
|
|
2015-01-09 |
13G/A
|
MECK / Mecklermedia Corporation
|
|
|
0 |
|
|
|
2014-12-05 |
13G/A
|
RPXC / RPX Corporation
|
|
|
2,399,190 |
|
|
|
2014-12-05 |
13G/A
|
ISSC / Innovative Solutions and Support, Inc.
|
|
|
432,463 |
|
|
|
2014-12-05 |
13G/A
|
CIDM / Cinedigm Corp - Class A
|
|
|
3,585,694 |
|
|
|
2014-11-10 |
13G/A
|
CIDM / Cinedigm Corp - Class A
|
|
|
5,566,904 |
|
|
|
2014-11-10 |
13G/A
|
ISSC / Innovative Solutions and Support, Inc.
|
|
|
1,050,000 |
|
|
|
2014-11-10 |
13G/A
|
RDWR / Radware Ltd.
|
|
|
1,866,100 |
|
|
|
2014-09-10 |
13G/A
|
ALXA / Alexza Pharmaceuticals, Inc.
|
|
|
637,764 |
|
|
|
2014-09-10 |
13G/A
|
LIQD / Liquid Holdings Group, Inc.
|
|
|
2,781,737 |
|
|
|
2014-08-07 |
13G
|
TSQ / Townsquare Media, Inc.
|
|
|
921,896 |
|
|
|
2014-08-07 |
13G/A
|
LIQD / Liquid Holdings Group, Inc.
|
|
|
4,148,587 |
|
|
|
2014-06-10 |
13G/A
|
SLCA / U.S. Silica Holdings, Inc.
|
|
|
2,635,576 |
|
|
|
2014-06-10 |
13G/A
|
TOWR / Tower International, Inc.
|
|
|
974,048 |
|
|
|
2014-06-10 |
13G
|
LIQD / Liquid Holdings Group, Inc.
|
|
|
7,352,472 |
|
|
|
2014-05-09 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
3,185,000 |
|
|
|
2014-05-09 |
13G/A
|
TXTR / Textura Corp.
|
|
|
2,703,490 |
|
|
|
2014-03-10 |
13G
|
BDSI / Biodelivery Sciences International
|
|
|
5,583,000 |
|
|
|
2014-02-12 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
38,680,976 |
|
|
|
2014-02-12 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
11,267,257 |
|
|
|
2014-02-12 |
13G/A
|
MECK / Mecklermedia Corporation
|
|
|
368,506 |
|
|
|
2014-02-12 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
|
12,643,898 |
|
|
|
2014-02-12 |
13G/A
|
DXCM / DexCom, Inc.
|
|
|
5,873,632 |
|
|
|
2014-02-12 |
13G/A
|
RDWR / Radware Ltd.
|
|
|
2,519,900 |
|
|
|
2014-02-12 |
13G
|
SLCA / U.S. Silica Holdings, Inc.
|
|
|
3,072,300 |
|
|
|
2014-02-12 |
13G/A
|
CIDM / Cinedigm Corp - Class A
|
|
|
7,982,387 |
|
|
|
2014-02-12 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
5,131,201 |
|
|
|
2014-02-12 |
13G/A
|
ALXA / Alexza Pharmaceuticals, Inc.
|
|
|
1,069,193 |
|
|
|
2014-02-12 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
3,254,960 |
|
|
|
2014-02-12 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
35,782,213 |
|
|
|
2014-02-12 |
13G
|
TOWR / Tower International, Inc.
|
|
|
1,029,027 |
|
|
|
2014-02-12 |
13G/A
|
EXAM / ExamWorks Group, Inc.
|
|
|
3,129,900 |
|
|
|
2014-02-12 |
13G/A
|
RPXC / RPX Corporation
|
|
|
2,912,100 |
|
|
|
2014-02-12 |
13G
|
TXTR / Textura Corp.
|
|
|
2,311,490 |
|
|
|
2014-02-12 |
13G
|
PINC / Premier, Inc.
|
|
|
1,935,888 |
|
|
|
2014-02-12 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
12,549,790 |
|
|
|
2014-02-12 |
13G/A
|
ISSC / Innovative Solutions and Support, Inc.
|
|
|
2,401,336 |
|
|
|
2014-02-12 |
13G
|
B0BK18905 / Central European Media Enterprises Ltd.
|
|
|
7,169,474 |
|
|
|
2014-02-10 |
13G/A
|
FWM / Fairway Group Holdings Corp.
|
|
|
0 |
|
|
|
2014-02-10 |
13G
|
FWM / Fairway Group Holdings Corp.
|
|
|
1,436,550 |
|
|
|
2014-01-10 |
13G/A
|
GEVO / Gevo, Inc.
|
|
|
2,485,000 |
|
|
|
2014-01-10 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
15,728,937 |
|
|
|
2013-10-10 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
2,887,672 |
|
|
|
2013-09-10 |
13G/A
|
EXAM / ExamWorks Group, Inc.
|
|
|
601,500 |
|
|
|
2013-09-10 |
13G/A
|
RGEN / Repligen Corporation
|
|
|
1,559,409 |
|
|
|
2013-09-10 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
|
5,521,566 |
|
|
|
2013-07-09 |
13G/A
|
MSPD / Mindspeed Technologies, Inc
|
|
|
2,023,389 |
|
|
|
2013-07-09 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
12,549,790 |
|
|
|
2013-06-07 |
13G/A
|
CPTS / CENTURY PLAZA TOWERS 2019-CPT CPTS 2019 CPT A 144A
|
|
|
0 |
|
|
|
2013-06-07 |
13G/A
|
NVMI / Nova Ltd.
|
|
|
1,286,534 |
|
|
|
2013-06-07 |
13G/A
|
|
|
|
0 |
|
|
|
2013-03-08 |
13G/A
|
PODD / Insulet Corporation
|
|
|
1,851,933 |
|
|
|
2013-02-12 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
31,942,154 |
|
|
|
2013-02-12 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
10,665,296 |
|
|
|
2013-02-12 |
13G/A
|
MECK / Mecklermedia Corporation
|
|
|
418,506 |
|
|
|
2013-02-12 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
|
12,828,164 |
|
|
|
2013-02-12 |
13G/A
|
DXCM / DexCom, Inc.
|
|
|
8,914,730 |
|
|
|
2013-02-12 |
13G/A
|
RDWR / Radware Ltd.
|
|
|
1,299,400 |
|
|
|
2013-02-12 |
13G/A
|
NVMI / Nova Ltd.
|
|
|
1,554,030 |
|
|
|
2013-02-12 |
13G/A
|
PODD / Insulet Corporation
|
|
|
4,245,519 |
|
|
|
2013-02-12 |
13G/A
|
CIDM / Cinedigm Corp - Class A
|
|
|
5,507,787 |
|
|
|
2013-02-12 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
5,438,183 |
|
|
|
2013-02-12 |
13G/A
|
MSPD / Mindspeed Technologies, Inc
|
|
|
3,475,364 |
|
|
|
2013-02-12 |
13G
|
ALXA / Alexza Pharmaceuticals, Inc.
|
|
|
1,244,970 |
|
|
|
2013-02-12 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
4,034,207 |
|
|
|
2013-02-12 |
13G/A
|
ZGNX / Zogenix Inc
|
|
|
31,032,213 |
|
|
|
2013-02-12 |
13G
|
GEVO / Gevo, Inc.
|
|
|
3,700,000 |
|
|
|
2013-02-12 |
13G/A
|
EXAM / ExamWorks Group, Inc.
|
|
|
4,057,759 |
|
|
|
2013-02-12 |
13G
|
RPXC / RPX Corporation
|
|
|
2,900,500 |
|
|
|
2013-02-12 |
13G
|
EXAM / ExamWorks Group, Inc.
|
|
|
984,588 |
|
|
|
2013-02-12 |
13G/A
|
RGEN / Repligen Corporation
|
|
|
2,747,500 |
|
|
|
2013-02-12 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
5,277,174 |
|
|
|
2013-02-12 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
12,538,268 |
|
|
|
2013-02-12 |
13G/A
|
ISSC / Innovative Solutions and Support, Inc.
|
|
|
2,449,549 |
|
|
|
2013-02-12 |
13G/A
|
CPTS / CENTURY PLAZA TOWERS 2019-CPT CPTS 2019 CPT A 144A
|
|
|
2,392,880 |
|
|
|
2013-02-12 |
13G
|
NKTR / Nektar Therapeutics
|
|
|
5,828,500 |
|
|
|
2013-02-12 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
18,279,209 |
|
|
|
2013-02-08 |
13G/A
|
CBST /
|
|
|
3,277,875 |
|
|
|
2013-01-10 |
13G/A
|
TNS / TNS, Inc.
|
|
|
346,800 |
|
|
|
2012-10-10 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
|
12,643,932 |
|
|
|
2012-10-10 |
13G/A
|
WD / Walker & Dunlop, Inc.
|
|
|
1,194,300 |
|
|
|
2012-08-10 |
13G/A
|
DXCM / DexCom, Inc.
|
|
|
7,752,258 |
|
|
|
2012-08-10 |
13G
|
ZGNX / Zogenix Inc
|
|
|
30,450,000 |
|
|
|
2012-06-07 |
13G/A
|
STRI / STR Holdings Inc
|
|
|
1,599,748 |
|
|
|
2012-06-07 |
13G/A
|
MSCC / Microsemi Corp.
|
|
|
4,183,072 |
|
|
|
2012-03-08 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
5,230,849 |
|
|
|
2012-02-10 |
13G/A
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
8,646,942 |
|
|
|
2012-02-10 |
13G/A
|
ALKS / Alkermes plc
|
|
|
4,451,691 |
|
|
|
2012-02-09 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
|
28,727,444 |
|
|
|
2012-02-09 |
13G
|
PLX / Protalix BioTherapeutics, Inc.
|
|
|
8,481,263 |
|
|
|
2012-02-09 |
13G/A
|
MECK / Mecklermedia Corporation
|
|
|
2,943,098 |
|
|
|
2012-02-09 |
13G/A
|
CORT / Corcept Therapeutics Incorporated
|
|
|
5,505,247 |
|
|
|
2012-02-09 |
13G/A
|
DXCM / DexCom, Inc.
|
|
|
4,876,053 |
|
|
|
2012-02-09 |
13G/A
|
RDWR / Radware Ltd.
|
|
|
1,391,438 |
|
|
|
2012-02-09 |
13G/A
|
NVMI / Nova Ltd.
|
|
|
1,841,149 |
|
|
|
2012-02-09 |
13G/A
|
PODD / Insulet Corporation
|
|
|
3,512,322 |
|
|
|
2012-02-09 |
13G/A
|
CIDM / Cinedigm Corp - Class A
|
|
|
4,422,787 |
|
|
|
2012-02-09 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
|
3,239,376 |
|
|
|
2012-02-09 |
13G/A
|
MSPD / Mindspeed Technologies, Inc
|
|
|
3,092,600 |
|
|
|
2012-02-09 |
13G/A
|
TNS / TNS, Inc.
|
|
|
3,410,495 |
|
|
|
2012-02-09 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
3,393,196 |
|
|
|
2012-02-09 |
13G/A
|
STRI / STR Holdings Inc
|
|
|
2,128,900 |
|
|
|
2012-02-09 |
13G/A
|
WD / Walker & Dunlop, Inc.
|
|
|
1,240,700 |
|
|
|
2012-02-09 |
13G/A
|
EXAM / ExamWorks Group, Inc.
|
|
|
4,418,617 |
|
|
|
2012-02-09 |
13G/A
|
MSCC / Microsemi Corp.
|
|
|
4,747,767 |
|
|
|
2012-02-09 |
13G/A
|
RGEN / Repligen Corporation
|
|
|
4,078,843 |
|
|
|
2012-02-09 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
6,876,305 |
|
|
|
2012-02-09 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
8,093,593 |
|
|
|
2012-02-09 |
13G/A
|
ISSC / Innovative Solutions and Support, Inc.
|
|
|
2,449,549 |
|
|
|
2012-02-09 |
13G/A
|
ALKS / Alkermes plc
|
|
|
6,474,088 |
|
|
|
2012-02-09 |
13G/A
|
CPTS / CENTURY PLAZA TOWERS 2019-CPT CPTS 2019 CPT A 144A
|
|
|
3,585,704 |
|
|
|
2012-02-09 |
13G/A
|
DYAX / Dyax Corp.
|
|
|
17,776,264 |
|
|
|
2012-02-09 |
13G/A
|
CBST /
|
|
|
5,439,340 |
|
|
|
2012-01-10 |
13G/A
|
BBI / Brickell Biotech Inc
|
|
|
6,876,305 |
|
|
|